Prostate Cancer
News and reporting on prostate cancer.
Updated NCCN Guidelines Adjust Ratings for Prostate Cancer Genetic Tests
The newest version ups its endorsement of somatic genomic testing to "recommended" for advanced cancers and shifts its recommendations on early-stage risk assays.
NCCN Adds Prostate Cancer to Genetic Risk Assessment Guidelines
The NCCN also recently updated genetic risk guidelines for colorectal, endometrial, and gastric cancers.
As the company explores new testing areas and technologies, the prostate cancer prognostic has become an important backbone.
Trinity Biotech Acquiring Prostate Cancer Test Developer EpiCapture for at Least $3M
Trinity also said it had acquired a 12.5 percent equity stake in Novus Diagnostics in a deal that was worth about $2.5 million.
UBS Initiates Coverage of Veracyte With Buy Rating
Analysts noted that they envision "durable growth" in Veracyte's Afirma and Decipher Prostate tests and "long-term growth potential" from its MRD testing business.
Aug 29, 2024
Aug 8, 2024
Local Coverage Determinations Roundup: Veracyte
Jul 8, 2024